IGM Biosciences, Inc. (IGMS)

IGM Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	113.11	121.92	134.04	241.08	35.89
Short-Term Investments	225.16	305.93	96.21	125.19	188.74
Cash & Cash Equivalents	338.27	427.85	230.24	366.27	224.63
Cash Growth	-20.94%	85.83%	-37.14%	63.05%	11205.18%
Other Current Assets	9.33	10.57	10.5	7	6.47
Total Current Assets	347.6	438.42	240.75	373.27	231.1
Property, Plant & Equipment	74.01	73.08	56.34	34.81	18.02
Long-Term Investments	0	0	0	0	11.97
Other Long-Term Assets	1.81	2	1.04	0.55	0.26
Total Long-Term Assets	75.81	75.08	57.38	35.36	30.25
Total Assets	423.41	513.5	298.13	408.63	261.35
Accounts Payable	1.33	2.51	5.58	7.92	3.09
Deferred Revenue	146.8	148.93	0	0	0
Current Debt	5.83	5.82	3.32	2.67	2.48
Other Current Liabilities	-111.48	-112.57	18.88	6.65	3.31
Total Current Liabilities	42.48	44.69	27.78	17.24	8.88
Long-Term Debt	34.67	35.36	25.44	9.58	12.24
Other Long-Term Liabilities	143.02	146.2	0	0	0
Total Long-Term Liabilities	177.7	181.55	25.44	9.58	12.24
Total Liabilities	220.18	226.24	53.22	26.82	21.12
Total Debt	40.51	41.17	28.76	12.24	14.73
Debt Growth	-1.62%	43.16%	134.88%	-16.86%	192.96%
Retained Earnings	-821.24	-574.83	-353.72	-188.56	-107.21
Comprehensive Income	0.15	-0.7	-0.07	0.03	0.04
Shareholders' Equity	203.23	287.26	244.91	381.82	240.23
Net Cash / Debt	297.76	386.68	201.48	354.03	209.91
Net Cash / Debt Growth	-22.99%	91.92%	-43.09%	68.66%	-
Net Cash Per Share	5.69	9.31	6.02	11.51	23.33
Working Capital	305.12	393.74	212.97	356.03	222.23
Book Value Per Share	3.88	6.92	7.32	12.42	26.71

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).